JDP Therapeutics, Inc. — Form D
JDP Therapeutics, Inc. of LANSDALE, PA, a company, filed a Form D exempt-offering notice with the SEC on 2016-06-22. The offering totals $17.0M, of which $2.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2016-06-22
- Form: D
- Accession: 0001677485-16-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $17.0M
- Amount sold: $2.0M
- Remaining: $15.0M
- Investors: 1
- Date of first sale: 2016-06-20
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-265592
Issuer
- Name: JDP Therapeutics, Inc.
- CIK: 0001488520
- Entity type: Corporation
- Jurisdiction: PENNSYLVANIA
- Incorporated: 2008
- Address: 823 JAYS DRIVE, LANSDALE, PA, 19446
- Phone: (215) 661-8557
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Jonathan H Black | Director | Lansdale, PA |
| Jie Du | Director | Lansdale, PA |
| John M Morrash | Director | Danboro, PA |
| Jie Du | Executive Officer | Lansdale, PA |
| Joshua M Tarnoff | Director | Radnor, PA |
| Joshua M Tarnoff | Executive Officer | Radnor, PA |
| Christopher M Cashman | Director | Bedford, MA |
Other filings by this issuer (4)
More